2012
 
 
 

2012 Publications:

 

 Weiner, J. P., Trish E. E., Abrams C., & Lemke K. (2012). Adjusting For Risk Selection In State Health Insurance Exchanges Will Be Critically Important And Feasible, But Not Easy. Health Affairs. 31(2), 306-315.  

Philipson, T. J., Eber M. R., Lakdawalla D. N., Corral M., Conti R., & Goldman D. P. (2012). An Analysis Of Whether Higher Health Care Spending In The United States Versus Europe Is ‘Worth It’ In The Case Of Cancer. Health Affairs. 31(4), 667-675.  

Sood, N., Sun E. C., & Zhuo X. (2012). Behind-the-Counter Statins: A Silver Bullet for Reducing Costs and Increasing Access? Health Services Research. 47(1pt1), 174-187.  

Ginsburg, P. B. (2012). Bending the Health Care Cost Curve. New England Journal of Medicine. 367(25), 2454-2456.  

Lakdawalla, D. N., & Zanjani G. (2012). Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer. Journal of Risk and Insurance. 79(2), 449-476.  

Suh, H. Sun, Hay J. W., Johnson K. A., & Doctor J. N. (2012). Comparative effectiveness of statin plus fibrate combination therapy and statin monotherapy in patients with type 2 diabetes: Use of propensity-score and instrumental variable methods to adjust for treatment-selection bias. Pharmacoepidemiology and Drug Safety. 21(5), 470-484.  

Jena, A. B., Sun E. C., & Goldman D. P. (2012). Confounding in the Association of Proton Pump Inhibitor Use With Risk of Community-Acquired Pneumonia. Journal of General Internal Medicine. 28(2), 223-230.  

Goldman, D. P., & Joyce G. F. (2012). Consumer Demand and Health Effects of Cost-Sharing. The Oxford Handbook of the Economics of the Biopharmaceutical Industry. 

Hay, J. W., Katon W. J., Ell K., Lee P-J., & Guterman J. J. (2012). Cost-Effectiveness Analysis of Collaborative Care Management of Major Depression among Low-Income, Predominantly Hispanics with Diabetes. Value in Health. 15(2), 249-254. 

Nichol, M. B., Wu J., Huang J., Denham D., Frencher S. K., & Jacobsen S. J. (2012). Cost-effectiveness of Prostate Health Index for prostate cancer detection. BJU International. 110(3), 353-362.  

Romley, J. A., Goldman D. P., Eber M. R., Dastani H., Kim E., & Raparla S. (2012). Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis. The American Journal of Managed Care. 18(8), 460-464. 

Darkow, T., Maclean R. J., Joyce G. F., Goldman D. P., & Lakdawalla D. N. (2012). Coverage and use of cancer therapies in the treatment of chronic myeloid leukemia. The American Journal of Managed Care. 18(11 Suppl), S272-8. 

Seabury, S. A., Chandra A., Lakdawalla D. N., & Jena A. B. (2012). Defense Costs of Medical Malpractice Claims. New England Journal of Medicine. 366(14), 1354-1356.  

Alley, D., & Crimmins E. M. (2012). The demography of aging and work. Aging and Work in The 21st Century. 7-24. 

Huckfeldt, P. J., Meeker D., Peters A. L., Guterman J. J., Diaz G., & Goldman D. P. (2012). Diabetes Management For Low-Income Patients In Los Angeles: Two Strategies Improved Disease Control In The Short Term. Health Affairs. 31(1), 168-176. 

S. Olshansky, J., Antonucci T., Berkman L., Binstock R. H., Boersch-Supan A., Cacioppo J. T., et al. (2012). Differences In Life Expectancy Due To Race And Educational Differences Are Widening, And Many May Not Catch Up. Health Affairs. 31(8), 1803-1813.  

Snider, J. Thornton, Romley J. A., Wong K. S., Zhang J., Eber M. R., & Goldman D. P. (2012). The Disability Burden of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease. 9(5), 513-521.  

Lakdawalla, D. N., & Philipson T. J. (2012). Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets. The Journal of Law & Economics. 55(1), 151-187.  

Beltrán-Sánchez, H., Crimmins E. M., & Finch C. E. (2012). Early cohort mortality predicts the rate of aging in the cohort: a historical analysis. Journal of Developmental Origins of Health and Disease. 3(05), 380–386.  

Perlroth, D. J., Bhattacharya J., Goldman D. P., & Garber A. M. (2012). An Economic Analysis of Conservative Management Versus Active Treatment for Men with Localized Prostate Cancer. Journal of the National Cancer Institute. Monographs. 2012(45), 250-257.  

Huckfeldt, P. J., Lakdawalla D. N., & Philipson T. J. (2012). Economics of Obesity. The Elgar Companion to Health Economics. 70-80. 

Rashid, N., McCombs J. S., & Schwartz E. (2012). Effect of Exenatide, Pen Insulin, and Vial Insulin on Patient Outcomes: A Retrospective Database Analysis of Persistence and First-Year Costs in a Commercially Insured Population⁎. Clinical Therapeutics. 34(5), 1145-1158.  

Clark, F., Jackson J., Carlson M., Chou C-P., Cherry B. J., Jordan-Marsh M., et al. (2012). Effectiveness of a lifestyle intervention in promoting the well-being of independently living older people: results of the Well Elderly 2 Randomised Controlled Trial. Journal of Epidemiology and Community Health. 66(9), 782-790.  

Zhou, Z-Y., & Hay J. W. (2012). Efficacy of Bypassing Agents in Patients With Hemophilia and Inhibitors: A Systematic Review and Meta-Analysis. Clinical Therapeutics. 34(2), 434-445.  

Romley, J. A., Goldman D. P., Solomon M. D., McFadden D. L., & Peters A. L. (2012). Exenatide Therapy and the Risk of Pancreatitis and Pancreatic Cancer in a Privately Insured Population. Diabetes Technology & Therapeutics. 14(10), 904-911.  

Best, J.H., Romley J. A., Goldman D. P., Conrad R. M., & Peters A. L. (2012). Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. The American Journal of Managed Care. 18(8 Suppl), s191-202. 

Wiegand, P., McCombs J. S., & Wang J. J. (2012). Factors of hyperlipidemia medication adherence in a nationwide health plan. The American Journal of Managed Care. 18(4), 193-199. 

Ginsburg, P. B. (2012). Fee-For-Service Will Remain A Feature Of Major Payment Reforms, Requiring More Changes In Medicare Physician Payment. Health Affairs. 31(9), 1977-1983.  

Huesch, M. D. (2012). Fitness Memberships and Favorable Selection in Medicare Advantage Plans. New England Journal of Medicine. 366(15), 1448-1450.  

Sood, N., & Wagner Z. (2012). For-profit sector immunization service provision: does low provision create a barrier to take-up? Health Policy and Planning. czs113.  

Sood, N., & Wagner Z. (2012). For-profit sector immunization service provision: does low provision create a barrier to take-up? Health Policy and Planning. czs113.  

Huesch, M. D., & Lakdawalla D. N. (2012). Freedom to innovate: The perils of centralized medical research. Archives of Internal Medicine. 172(21), 1692-1693.  

Crimmins, E. M., & Finch C. E. (2012). The Genetics of Age-Related Health Outcomes. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences. 67A(5), 467-469.  

Berenson, R. A., Ginsburg P. B., Christianson J. B., & Yee T. (2012). The growing power of some providers to win steep payment increases from insurers suggests policy remedies may be needed. Health Affairs. 31(5), 973-981.  

Haviland, A. M., M. Marquis S., McDevitt R. D., & Sood N. (2012). Growth Of Consumer-Directed Health Plans To One-Half Of All Employer-Sponsored Insurance Could Save $57 Billion Annually. Health Affairs. 31(5), 1009-1015.  

Solé-Auró, A., Guillén M., & Crimmins E. M. (2012). Health care usage among immigrants and native-born elderly populations in eleven European countries: Results from SHARE. European Journal of Health Economics. 13(6), 741-754.  

Burger, N. E., Kopf D., Spreng C. P., Yoong J., & Sood N. (2012). Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya. PLoS ONE. 7(2), e27885.  

Lakdawalla, D. N., Romley J. A., Sanchez Y., Maclean R. J., Penrod J. R., & Philipson T. J. (2012). How Cancer Patients Value Hope And The Implications For Cost-Effectiveness Assessments Of High-Cost Cancer Therapies. Health Affairs. 31(4), 676-682.  

Turpcu, A., Bleichrodt H., Le Q. A., & Doctor J. N. (2012). How to Aggregate Health? Separability and the Effect of Framing. Medical Decision Making. 32(2), 259-265. 

McCombs, J. S., Shin J., Hines P., Yuan Y., & Saab S. (2012). Impact of drug therapy adherence in patients with hepatitis C. American Journal of Pharmacy Benefits. 4.

Lakdawalla, D. N., & Sood N. (2012). Incentives to Innovate. The Oxford Handbook of the Economics of the Biopharmaceutical Industry. 

Fairlie, R. W., Krashinsky H., Zissimopoulos J. M., & Kumar K. B. (2012). Indian entrepreneurial success in the united states, canada, and the united kingdom. Research in Labor Economics. 36, 285. 

Snider, J. Thornton, Luna Y., Wong K. S., Zhang J., Chen S. S., Gless P. J., et al. (2012). Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Current Medical Research and Opinion. 28(12), 1959-1967.  

Grabowski, D. C., Lakdawalla D. N., Goldman D. P., Eber M. R., Liu L. Z., Abdelgawad T., et al. (2012). The Large Social Value Resulting From Use Of Statins Warrants Steps To Improve Adherence And Broaden Treatment. Health Affairs. 31(10), 2276-2285.  
Huesch, M. D. (2012). Long-term impact of medicare managed care on patients treated for coronary artery disease. Medical Care. 50(1), 18-26.  

Huesch, M. D., Østbye T., & Ong M. K. (2012). Measuring the Effect of Policy Interventions at the Population Level: Some Methodological Concerns. Health Economics. 21(10), 1234-1249.  

Lakdawalla, D. N., Eber M. R., Forma F. M., Sullivan J., Michaud P-C., Bradley L. A., et al. (2012). Measuring the value of better diabetes management. The American Journal of Managed Care. 19 Spec No. 2, E11-E11. 

Grabowski, D. C., Huckfeldt P. J., Sood N., Escarce J. J., & Newhouse J. P. (2012). Medicare Postacute Care Payment Reforms Have Potential To Improve Efficiency Of Care, But May Need Changes To Cut Costs. Health Affairs. 31(9), 1941-1950.  

Yen, L., Wu J., Hodgkins P. I., Cohen R. D., & Nichol M. B. (2012). Medication use patterns and predictors of nonpersistence and nonadherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis. Journal of Managed Care Pharmacy. 18(9 A), 701-712. 

Huesch, M. D. (2012). One and done? Equality of opportunity and repeated access to scarce, indivisible medical resources. BMC Medical Ethics. 13(1), 11.  

Sanchez, Y., Penrod J. R., Qiu X. L., Romley J. A., Snider J. Thornton, & Philipson T. J. (2012). The option value of innovative treatments in the context of chronic myeloid leukemia. The American Journal of Managed Care. 18(11 Suppl), S265-71. 

Jena, A. B., Chandra A., Lakdawalla D. N., & Seabury S. A. (2012). Outcomes of medical malpractice litigation against us physicians. Archives of Internal Medicine. 172(11), 892-894.  

Karaca-Mandic, P., Jena A. B., Joyce G. F., & Goldman D. P. (2012). Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA. 307(12), 1284-1291.  

Seabury, S. A., Goldman D. P., Maclean R. J., Penrod J. R., & Lakdawalla D. N. (2012). Patients Value Metastatic Cancer Therapy More Highly Than Is Typically Shown Through Traditional Estimates. Health Affairs. 31(4), 691-699.  

Seabury, S. A., Lakdawalla D. N., & Goldman D. P. (2012). Patients’ Willingness To Pay: The Authors Reply. Health Affairs. 31(8), 1909-1909.  

Lakdawalla, D. N., Goldman D. P., & Philipson T. J. (2012). PIH24 Modeling the Health and Medical Care Spending of the Future Elderly: An Update Using the Future Elderly Model. Value in Health. 15(4), A195-A196.  

Sood, N., & Higgins A. (2012). Posing A Framework To Guide Government’s Role In Payment And Delivery System Reform. Health Affairs. 31(9), 2043-2050.  

Kim, J. Ki, Baker L. A., Seirawan H., & Crimmins E. M. (2012). Prevalence of oral health problems in U.S. adults, NHANES 1999-2004: Exploring differences by age, education, and race/ethnicity. Special Care in Dentistry. 32(6), 234-241.  

Shin, J., McCombs J. S., Sanchez R. J., Udall M., Deminski M. C., & Cheetham T. C. (2012). Primary nonadherence to medications in an integrated healthcare setting. The American Journal of Managed Care. 18(8), 426-434. 

Wallner, L. P., Frencher S. K., Hsu J-W. Y., Loo R. K., Huang J., Nichol M. B., et al. (2012). Prostate cancer screening trends in a large, integrated health care system. The Permanente Journal. 16(3), 4-9. 

Poon, J-L., Zhou Z-Y., Doctor J. N., Wu J., Ullman M. M., Ross C., et al. (2012). Quality of life in haemophilia A: Hemophilia Utilization Group Study Va (HUGS-Va). Haemophilia. 18(5), 699-707.  

Philipson, T. J., Sun E. C., Goldman D. P., & Jena A. B. (2012). A Reexamination of the Costs of Medical R&D Regulation. Forum for Health Economics and Policy. 15(2), 1-28. 

Levine, M. E., & Crimmins E. M. (2012). Sarcopenic Obesity and Cognitive Functioning: The Mediating Roles of Insulin Resistance and Inflammation? Current Gerontology and Geriatrics Research. 2012, e826398.  

White, C., & Ginsburg P. B. (2012). Slower Growth in Medicare Spending — Is This the New Normal? New England Journal of Medicine. 366(12), 1073-1075.  

Yee, T., Christianson J. B., & Ginsburg P. B. (2012). Small employers and self-insured health benefits: too small to succeed? Issue brief (Center for Studying Health System Change). 1-4. 

Romley, J. A., Sanchez Y., Penrod J. R., & Goldman D. P. (2012). Survey Results Show That Adults Are Willing To Pay Higher Insurance Premiums For Generous Coverage Of Specialty Drugs. Health Affairs. 31(4), 683-690.  

Jena, A. B., Romley J. A., Newton-Cheh C., & Noseworthy P. (2012). Therapeutic hypothermia for cardiac arrest: Real-world utilization trends and hospital mortality. Journal of Hospital Medicine. 7(9), 684-689.  

Perlroth, D. J., & Thompson S. F. (2012). Timing is everything: time to ADT and chemotherapy initiation for treatment of metastatic prostate cancer. 

Winstein, C. J., Requejo P. S., Zelinski E. M., Mulroy S. J., & Crimmins E. M. (2012). A Transformative Subfield in Rehabilitation Science at the Nexus of New Technologies, Aging, and Disability. Frontiers in Psychology. 3.

Perlroth, Y. Luna Danie (2012). Treating people right: Who goes untreated with systemic therapy for metastatic prostate cancer (mPC)? Journal of Clinical Oncology. 30(5).

Freedman, V. A., Spillman B. C., Andreski P. M., Cornman J. C., Crimmins E. M., Kramarow E., et al. (2012). Trends in Late-Life Activity Limitations in the United States: An Update From Five National Surveys. Demography. 50(2), 661-671.  

Barcellos, S. Helena, Goldman D. P., & Smith J. Patrick (2012). Undiagnosed Disease, Especially Diabetes, Casts Doubt On Some Of Reported Health ‘Advantage’ Of Recent Mexican Immigrants. Health Affairs. 31(12), 2727-2737.  

Michaud, P-C., Goldman D. P., Lakdawalla D. N., Zheng Y., & Gailey A. H. (2012). The value of medical and pharmaceutical interventions for reducing obesity. Journal of Health Economics. 31(4), 630-643.  

Yin, W., Penrod J. R., Maclean R. J., Lakdawalla D. N., & Philipson T. J. (2012). Value of survival gains in chronic myeloid leukemia. The American Journal of Managed Care. 18(11 Suppl), S257-264. 

Lakdawalla, D. N., & Seabury S. A. (2012). The welfare effects of medical malpractice liability. International Review of Law and Economics. 32(4), 356-369.  

Fonseca, R., Mullen K. J., Zamarro G., & Zissimopoulos J. M. (2012). What Explains the Gender Gap in Financial Literacy? The Role of Household Decision Making. Journal of Consumer Affairs. 46(1), 90-106.  

Hay, J. W. (2012). What is more valuable: Fenofibrate patents or fenofibrate clinical outcomes? Archives of Internal Medicine. 172(19), 1521-1522.  

Szczerba, R. J., & Huesch M. D. (2012). Why technology matters as much as science in improving healthcare. BMC Medical Informatics and Decision Making. 12(1), 103. 

O'Leary, P., Boden L. I., Seabury S. A., Ozonoff A., & Scherer E. (2012). Workplace injuries and the take-up of social security disability benefits. Social Security Bulletin. 72(3), 1-18.